{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T11:06:07Z","timestamp":1794740767370,"version":"4.9.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T00:00:00Z","timestamp":1629244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T00:00:00Z","timestamp":1629244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To assess the effects of Epstein\u2013Barr virus (EBV) and human papillomavirus (HPV) infection on the tumor microenvironment, we examined the relationship between viral infection status, macrophage migration inhibitory factor (MIF), and tumor-associated macrophages in nasopharyngeal carcinoma (NPC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A tissue microarray containing 150 cores from 90 patients with NPC and six with chronic inflammation was used. EBV and HPV status were detected using in situ hybridization with commercial EBER1 and HPV16\/18 probes. Immunofluorescence double staining of MIF, pan-macrophage marker CD68, M1 macrophage marker CD11c, and M2 macrophage marker CD163 were analyzed using the same tissue microarray. The levels of these markers between NPC and inflammation cases and between tumor nests and stroma were compared. Correlations among these markers were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We found EBER1(+) cases in 90% of NPC patients, including 10% EBV\/HPV co-infection. M1 macrophages mainly infiltrated the tumor nest, while M2 macrophages infiltrated the tumor stroma. We found a significant positive correlation between EBER1 levels and MIF levels in tumor nests and a significant positive correlation between HPV16\/18 and CD11c(+) cell levels in NPC tissues.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>It is suggested that MIF is associated with EBV, and M1 macrophage infiltration is affected by HPV status in NPC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-021-08675-x","type":"journal-article","created":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T02:24:18Z","timestamp":1629253458000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Influence of Epstein\u2013Barr virus and human papillomavirus infection on macrophage migration inhibitory factor and macrophage polarization in nasopharyngeal carcinoma"],"prefix":"10.1186","volume":"21","author":[{"given":"Guofei","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Midorikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Oikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatasu","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Ishinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangwu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,18]]},"reference":[{"issue":"10192","key":"8675_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","volume":"394","author":"YP Chen","year":"2019","unstructured":"Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64\u201380. https:\/\/doi.org\/10.1016\/S0140-6736(19)30956-0.","journal-title":"Lancet"},{"key":"8675_CR2","doi-asserted-by":"publisher","first-page":"101890","DOI":"10.1016\/j.ctrv.2019.101890","volume":"79","author":"AWM Lee","year":"2019","unstructured":"Lee AWM, Ng WT, Chan JYW, Corry J, Makitie A, Mendenhall WM, et al. Management of locally recurrent nasopharyngeal carcinoma. Cancer Treat Rev. 2019;79:101890. https:\/\/doi.org\/10.1016\/j.ctrv.2019.101890.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"8675_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12943-020-01292-5","volume":"20","author":"YP Chen","year":"2021","unstructured":"Chen YP, Lv JW, Mao YP, Li XM, Li JY, Wang YQ, et al. Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responses. Mol Cancer. 2021;20(1):14. https:\/\/doi.org\/10.1186\/s12943-020-01292-5.","journal-title":"Mol Cancer"},{"issue":"10022","key":"8675_CR4","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/S0140-6736(15)00055-0","volume":"387","author":"MLK Chua","year":"2016","unstructured":"Chua MLK, Wee JTS, Hui EP, Chan ATC. Nasopharyngeal carcinoma. Lancet. 2016;387(10022):1012\u201324. https:\/\/doi.org\/10.1016\/S0140-6736(15)00055-0.","journal-title":"Lancet"},{"issue":"2","key":"8675_CR5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3390\/pathogens7020040","volume":"7","author":"GW Tan","year":"2018","unstructured":"Tan GW, Visser L, Tan LP, van den Berg A, Diepstra A. The Microenvironment in Epstein-Barr Virus-Associated Malignancies. Pathogens. 2018;7(2):40.","journal-title":"Pathogens"},{"issue":"1","key":"8675_CR6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12929-019-0568-z","volume":"26","author":"Y Chen","year":"2019","unstructured":"Chen Y, Song Y, Du W, Gong L, Chang H, Zou Z. Tumor-associated macrophages: an accomplice in solid tumor progression. J Biomed Sci. 2019;26(1):78. https:\/\/doi.org\/10.1186\/s12929-019-0568-z.","journal-title":"J Biomed Sci"},{"issue":"3","key":"8675_CR7","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1172\/JCI59643","volume":"122","author":"A Sica","year":"2012","unstructured":"Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest. 2012;122(3):787\u201395. https:\/\/doi.org\/10.1172\/JCI59643.","journal-title":"J Clin Invest"},{"issue":"1","key":"8675_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12967-019-02191-0","volume":"18","author":"M Weber","year":"2020","unstructured":"Weber M, Wehrhan F, Baran C, Agaimy A, Buttner-Herold M, Ozturk H, et al. Malignant transformation of oral leukoplakia is associated with macrophage polarization. J Transl Med. 2020;18(1):11. https:\/\/doi.org\/10.1186\/s12967-019-02191-0.","journal-title":"J Transl Med"},{"issue":"1","key":"8675_CR9","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/1471-2407-12-306","volume":"12","author":"C Medrek","year":"2012","unstructured":"Medrek C, Ponten F, Jirstrom K, Leandersson K. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients. BMC Cancer. 2012;12(1):306. https:\/\/doi.org\/10.1186\/1471-2407-12-306.","journal-title":"BMC Cancer"},{"issue":"1","key":"8675_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3390\/cells10010159","volume":"10","author":"H Taubert","year":"2021","unstructured":"Taubert H, Eckstein M, Epple E, Jung R, Weigelt K, Lieb V, et al. Immune Cell-Associated Protein Expression Helps to Predict Survival in Muscle-Invasive Urothelial Bladder Cancer Patients after Radical Cystectomy and Optional Adjuvant Chemotherapy. Cells. 2021;10(1):159.","journal-title":"Cells"},{"issue":"7","key":"8675_CR11","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.11.020","volume":"22","author":"KY Cho","year":"2013","unstructured":"Cho KY, Miyoshi H, Kuroda S, Yasuda H, Kamiyama K, Nakagawara J, et al. The phenotype of infiltrating macrophages influences arteriosclerotic plaque vulnerability in the carotid artery. J Stroke Cerebrovasc Dis. 2013;22(7):910\u20138. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2012.11.020.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"1\u20132","key":"8675_CR12","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.jim.2011.10.013","volume":"375","author":"CA Ambarus","year":"2012","unstructured":"Ambarus CA, Krausz S, van Eijk M, Hamann J, Radstake TR, Reedquist KA, et al. Systematic validation of specific phenotypic markers for in vitro polarized human macrophages. J Immunol Methods. 2012;375(1\u20132):196\u2013206. https:\/\/doi.org\/10.1016\/j.jim.2011.10.013.","journal-title":"J Immunol Methods"},{"issue":"4","key":"8675_CR13","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.3892\/ol.2016.4929","volume":"12","author":"N Kindt","year":"2016","unstructured":"Kindt N, Journe F, Laurent G, Saussez S. Involvement of macrophage migration inhibitory factor in cancer and novel therapeutic targets. Oncol Lett. 2016;12(4):2247\u201353. https:\/\/doi.org\/10.3892\/ol.2016.4929.","journal-title":"Oncol Lett"},{"issue":"12","key":"8675_CR14","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1002\/hed.24939","volume":"39","author":"JR Lechien","year":"2017","unstructured":"Lechien JR, Nassri A, Kindt N, Brown DN, Journe F, Saussez S. Role of macrophage migration inhibitory factor in head and neck cancer and novel therapeutic targets: a systematic review. Head Neck. 2017;39(12):2573\u201384. https:\/\/doi.org\/10.1002\/hed.24939.","journal-title":"Head Neck"},{"key":"8675_CR15","doi-asserted-by":"crossref","unstructured":"Barbosa de Souza Rizzo M, Brasilino de Carvalho M, Kim EJ, Rendon BE, Noe JT, Darlene Wise A, Mitchell RA. Oral squamous carcinoma cells promote macrophage polarization in an MIF-dependent manner. QJM. 2018;111(11):769\u201378.","DOI":"10.1093\/qjmed\/hcy163"},{"issue":"1","key":"8675_CR16","doi-asserted-by":"publisher","first-page":"106","DOI":"10.7150\/ijms.7264","volume":"11","author":"XJ Pei","year":"2014","unstructured":"Pei XJ, Wu TT, Li B, Tian XY, Li Z, Yang QX. Increased expression of macrophage migration inhibitory factor and DJ-1 contribute to cell invasion and metastasis of nasopharyngeal carcinoma. Int J Med Sci. 2014;11(1):106\u201315. https:\/\/doi.org\/10.7150\/ijms.7264.","journal-title":"Int J Med Sci"},{"issue":"11","key":"8675_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113702","volume":"9","author":"Z Deng","year":"2014","unstructured":"Deng Z, Uehara T, Maeda H, Hasegawa M, Matayoshi S, Kiyuna A, et al. Epstein-Barr virus and human papillomavirus infections and genotype distribution in head and neck cancers. PLoS One. 2014;9(11):e113702. https:\/\/doi.org\/10.1371\/journal.pone.0113702.","journal-title":"PLoS One"},{"issue":"3","key":"8675_CR18","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/cncr.31031","volume":"124","author":"WB Huang","year":"2018","unstructured":"Huang WB, Chan JYW, Liu DL. Human papillomavirus and World Health Organization type III nasopharyngeal carcinoma: multicenter study from an endemic area in southern China. Cancer. 2018;124(3):530\u20136. https:\/\/doi.org\/10.1002\/cncr.31031.","journal-title":"Cancer"},{"issue":"3","key":"8675_CR19","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.ijrobp.2013.11.246","volume":"88","author":"MH Stenmark","year":"2014","unstructured":"Stenmark MH, McHugh JB, Schipper M, Walline HM, Komarck C, Feng FY, et al. Nonendemic HPV-positive nasopharyngeal carcinoma: association with poor prognosis. Int J Radiat Oncol Biol Phys. 2014;88(3):580\u20138. https:\/\/doi.org\/10.1016\/j.ijrobp.2013.11.246.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"8675_CR20","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.anl.2016.07.015","volume":"44","author":"M Kano","year":"2017","unstructured":"Kano M, Kondo S, Wakisaka N, Moriyama-Kita M, Nakanishi Y, Endo K, et al. The influence of human papillomavirus on nasopharyngeal carcinoma in Japan. Auris Nasus Larynx. 2017;44(3):327\u201332. https:\/\/doi.org\/10.1016\/j.anl.2016.07.015.","journal-title":"Auris Nasus Larynx"},{"issue":"1","key":"8675_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4149\/neo_2016_013","volume":"63","author":"M Svajdler Jr","year":"2016","unstructured":"Svajdler M Jr, Kaspirkova J, Mezencev R, Laco J, Torday T, Dubinsky P, et al. Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a non-endemic eastern european population. Neoplasma. 2016;63(1):107\u201314. https:\/\/doi.org\/10.4149\/neo_2016_013.","journal-title":"Neoplasma"},{"issue":"2","key":"8675_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.virusres.2005.04.019","volume":"113","author":"X Song","year":"2005","unstructured":"Song X, Tao YG, Zeng L, Deng XY, Lee LM, Gong JP, et al. Latent membrane protein 1 encoded by Epstein-Barr virus modulates directly and synchronously cyclin D1 and p16 by newly forming a c-Jun\/Jun B heterodimer in nasopharyngeal carcinoma cell line. Virus Res. 2005;113(2):89\u201399. https:\/\/doi.org\/10.1016\/j.virusres.2005.04.019.","journal-title":"Virus Res"},{"issue":"5","key":"8675_CR23","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.3892\/mmr.2016.4992","volume":"13","author":"W Xiao","year":"2016","unstructured":"Xiao W, Dong X, Zhao H, Han S, Nie R, Zhang X, et al. Expression of MIF and c-erbB-2 in endometrial cancer. Mol Med Rep. 2016;13(5):3828\u201334. https:\/\/doi.org\/10.3892\/mmr.2016.4992.","journal-title":"Mol Med Rep"},{"issue":"10","key":"8675_CR24","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1002\/ijc.25918","volume":"129","author":"YM Zhao","year":"2011","unstructured":"Zhao YM, Wang L, Dai Z, Wang DD, Hei ZY, Zhang N, et al. Validity of plasma macrophage migration inhibitory factor for diagnosis and prognosis of hepatocellular carcinoma. Int J Cancer. 2011;129(10):2463\u201372. https:\/\/doi.org\/10.1002\/ijc.25918.","journal-title":"Int J Cancer"},{"issue":"6","key":"8675_CR25","doi-asserted-by":"publisher","first-page":"101042832092452","DOI":"10.1177\/1010428320924524","volume":"42","author":"L Olsson","year":"2020","unstructured":"Olsson L, Lindmark G, Hammarstrom ML, Hammarstrom S, Sitohy B. Evaluating macrophage migration inhibitory factor 1 expression as a prognostic biomarker in colon cancer. Tumour Biol. 2020;42(6):1010428320924524. https:\/\/doi.org\/10.1177\/1010428320924524.","journal-title":"Tumour Biol"},{"issue":"12","key":"8675_CR26","first-page":"3755","volume":"8","author":"M Tomiyasu","year":"2002","unstructured":"Tomiyasu M, Yoshino I, Suemitsu R, Okamoto T, Sugimachi K. Quantification of macrophage migration inhibitory factor mRNA expression in non-small cell lung cancer tissues and its clinical significance. Clin Cancer Res. 2002;8(12):3755\u201360.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"8675_CR27","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/jso.21728","volume":"102","author":"B Liao","year":"2010","unstructured":"Liao B, Zhong BL, Li Z, Tian XY, Li Y, Li B. Macrophage migration inhibitory factor contributes angiogenesis by up-regulating IL-8 and correlates with poor prognosis of patients with primary nasopharyngeal carcinoma. J Surg Oncol. 2010;102(7):844\u201351. https:\/\/doi.org\/10.1002\/jso.21728.","journal-title":"J Surg Oncol"},{"issue":"5","key":"8675_CR28","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1309\/GFCLLRH8A68XKMJN","volume":"129","author":"H Lee","year":"2008","unstructured":"Lee H, Rhee H, Kang HJ, Kim HS, Min BS, Kim NK, et al. Macrophage migration inhibitory factor may be used as an early diagnostic marker in colorectal carcinomas. Am J Clin Pathol. 2008;129(5):772\u20139. https:\/\/doi.org\/10.1309\/GFCLLRH8A68XKMJN.","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"8675_CR29","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.3892\/ol.2014.2513","volume":"8","author":"DES MB","year":"2014","unstructured":"MB DES, Curioni OA, Kanda JL, MB DEC. Serum and salivary macrophage migration inhibitory factor in patients with oral squamous cell carcinoma. Oncol Lett. 2014;8(5):2267\u201375. https:\/\/doi.org\/10.3892\/ol.2014.2513.","journal-title":"Oncol Lett"},{"issue":"6","key":"8675_CR30","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1136\/gut.2005.078113","volume":"55","author":"XX He","year":"2006","unstructured":"He XX, Yang J, Ding YW, Liu W, Shen QY, Xia HH. Increased epithelial and serum expression of macrophage migration inhibitory factor (MIF) in gastric cancer: potential role of MIF in gastric carcinogenesis. Gut. 2006;55(6):797\u2013802. https:\/\/doi.org\/10.1136\/gut.2005.078113.","journal-title":"Gut"},{"key":"8675_CR31","doi-asserted-by":"crossref","first-page":"153303382093577","DOI":"10.1177\/1533033820935773","volume":"19","author":"N Xue","year":"2020","unstructured":"Xue N, Xing S, Ma W, Sheng J, Huang Z, Xu Q. Combination of plasma MIF and VCA-IgA improves the diagnostic specificity for patients with nasopharyngeal carcinoma. Technol Cancer Res Treat. 2020;19:1533033820935773.","journal-title":"Technol Cancer Res Treat"},{"key":"8675_CR32","doi-asserted-by":"publisher","first-page":"609948","DOI":"10.3389\/fimmu.2020.609948","volume":"11","author":"JT Noe","year":"2020","unstructured":"Noe JT, Mitchell RA. MIF-dependent control of tumor immunity. Front Immunol. 2020;11:609948. https:\/\/doi.org\/10.3389\/fimmu.2020.609948.","journal-title":"Front Immunol"},{"issue":"8","key":"8675_CR33","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1080\/00016489.2017.1296585","volume":"137","author":"H Huang","year":"2017","unstructured":"Huang H, Liu X, Zhao F, Lu J, Zhang B, Peng X, et al. M2-polarized tumour-associated macrophages in stroma correlate with poor prognosis and Epstein-Barr viral infection in nasopharyngeal carcinoma. Acta Otolaryngol. 2017;137(8):888\u201394. https:\/\/doi.org\/10.1080\/00016489.2017.1296585.","journal-title":"Acta Otolaryngol"},{"issue":"1","key":"8675_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12865-018-0241-4","volume":"19","author":"J Jackute","year":"2018","unstructured":"Jackute J, Zemaitis M, Pranys D, Sitkauskiene B, Miliauskas S, Vaitkiene S, et al. Distribution of M1 and M2 macrophages in tumor islets and stroma in relation to prognosis of non-small cell lung cancer. BMC Immunol. 2018;19(1):3. https:\/\/doi.org\/10.1186\/s12865-018-0241-4.","journal-title":"BMC Immunol"},{"issue":"1","key":"8675_CR35","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s43046-020-0018-8","volume":"32","author":"SE Mwafy","year":"2020","unstructured":"Mwafy SE, El-Guindy DM. Pathologic assessment of tumor-associated macrophages and their histologic localization in invasive breast carcinoma. J Egypt Natl Canc Inst. 2020;32(1):6. https:\/\/doi.org\/10.1186\/s43046-020-0018-8.","journal-title":"J Egypt Natl Canc Inst"},{"issue":"39","key":"8675_CR36","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000021999","volume":"99","author":"YL Chen","year":"2020","unstructured":"Chen YL. Prognostic significance of tumor-associated macrophages in patients with nasopharyngeal carcinoma: a meta-analysis. Medicine. 2020;99(39):e21999. https:\/\/doi.org\/10.1097\/MD.0000000000021999.","journal-title":"Medicine"},{"issue":"7","key":"8675_CR37","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.jcms.2014.01.035","volume":"42","author":"M Weber","year":"2014","unstructured":"Weber M, Buttner-Herold M, Hyckel P, Moebius P, Distel L, Ries J, et al. Small oral squamous cell carcinomas with nodal lymphogenic metastasis show increased infiltration of M2 polarized macrophages--an immunohistochemical analysis. J Craniomaxillofac Surg. 2014;42(7):1087\u201394. https:\/\/doi.org\/10.1016\/j.jcms.2014.01.035.","journal-title":"J Craniomaxillofac Surg"},{"issue":"1","key":"8675_CR38","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1183\/09031936.00065708","volume":"33","author":"CM Ohri","year":"2009","unstructured":"Ohri CM, Shikotra A, Green RH, Waller DA, Bradding P. Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival. Eur Respir J. 2009;33(1):118\u201326. https:\/\/doi.org\/10.1183\/09031936.00065708.","journal-title":"Eur Respir J"},{"issue":"48","key":"8675_CR39","doi-asserted-by":"publisher","first-page":"6246","DOI":"10.1038\/onc.2016.160","volume":"35","author":"A Ghoochani","year":"2016","unstructured":"Ghoochani A, Schwarz MA, Yakubov E, Engelhorn T, Doerfler A, Buchfelder M, et al. MIF-CD74 signaling impedes microglial M1 polarization and facilitates brain tumorigenesis. Oncogene. 2016;35(48):6246\u201361. https:\/\/doi.org\/10.1038\/onc.2016.160.","journal-title":"Oncogene"},{"issue":"6","key":"8675_CR40","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.4049\/jimmunol.1201650","volume":"190","author":"K Yaddanapudi","year":"2013","unstructured":"Yaddanapudi K, Putty K, Rendon BE, Lamont GJ, Faughn JD, Satoskar A, et al. Control of tumor-associated macrophage alternative activation by macrophage migration inhibitory factor. J Immunol. 2013;190(6):2984\u201393. https:\/\/doi.org\/10.4049\/jimmunol.1201650.","journal-title":"J Immunol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08675-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-08675-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08675-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T02:25:40Z","timestamp":1629253540000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-08675-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,18]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8675"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-08675-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-453222\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,18]]},"assertion":[{"value":"23 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"929"}}